1-3 of 3
Qinghong Yu
Close
Sort by
Journal Articles

Comparison of ATG-Based Immunosuppressive Treatment and Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Transfusion-Dependent Non-Severe Aplastic Anemia: A Single Center, Retrospective Analysis

Yuzhu Li, Yingying Shen, Wenbin Liu, Qi Liu, Ying Chen, Shan Liu, Yun Zhang, Shu Deng, Haifeng Zhuang, Zhiping Hu, Qinghong Yu, Shengyun Lin, Yuhong Zhou, Jianping Shen, Baodong Ye, Dijiong Wu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12950–12951.
https://doi.org/10.1182/blood-2022-160022
Published: 2022
Journal Articles

Whole-Exome Sequencing Identifies Fanc Heterozygous Germline Mutation As an Adverse Factor for Immunosuppressive Therapy in Chinese Aplastic Anemia Patients Aged 40 or Younger: A Single-Center Retrospective Study

Yingying Shen, Qi Liu, Wenbin Liu, Huijin Hu, Yuechao Zhao, Hangchao Li, Yuzhu Li, Ying Chen, Shan Liu, Qinghong Yu, Haifeng Zhuang, Zhiping Hu, Shu Deng, Jianping Shen, Shengyun Lin, Yiping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu
Journal: Blood
Blood (2022) 140 (Supplement 1): 2432–2433.
https://doi.org/10.1182/blood-2022-164573
Published: 2022
Journal Articles

Combination Chemotherapy Including Velcade in Patients with Refractory or Relapsed Multiple Myeloma.

YuHong Zhou, QingHong Yu, ZhiPing Hu, BaoDong Ye, YiPing Shen, JianPing Shen, LongXi Yu
Journal: Blood
Blood (2006) 108 (11): 5090.
https://doi.org/10.1182/blood.V108.11.5090.5090
Published: 2006